Member Info for Doc83

Matterhorn - good to see you back after what must have been a much needed holiday. Mine is booked for a few weeks time!

I love the line “we need a shareholder who can walk in with the proverbial baseball bat mentality and kick some a*s”! I expect some heads to roll and/or some of the more expensive recent recruits to depart following the next AGM.

I’d agree that Polygon know as little as we do. But for a fraction of their overall investment they have managed to gain significant control and influence over Synairgen.

Of course, we still need positive news from the SPRINTER deep dive (not massively hopeful) and ACTIV-2 P2 data reveal (a bit more hopeful). My only nervousness with ACTIV data is that (IMO) SAB’s wasn’t particularly amazing and yet was put through to P3…

Manifesto - you need to get a job at a hospital informing the terminally ill their days are numbered. I think you’d still manage to put a positive spin on it and give them hope!

TipTop, even if there is another bidder, they’ll have to have Polygon on their side. Polygon won’t let their now 26% holding go too cheaply.

Well I must say that has surprised me. They’ve had ample opportunity to top up around these levels. I guess it must be on the back of yesterday’s interview and news, not that there was much actual news!

I thought they’d decided 25% was enough but 29.9% must surely now be the target.

Manifesto - I stand corrected. I have just done the sums and I would guess £1.20 is their average in price.

However, I still maintain if Polygon could get out at breakeven or even close to it, they would. There are positives and as a LTH who is deep in this, I want us to do well. But I also appreciate this could now take a long time to come good...time is money. And £25m in the grand scheme of things isn't that much. We have lots of big salaries to pay for people we don't now need...manufacturing?! I think the AGM will see some big changes.

My point with takeovers is that large pharma have all the power now. If we'd have passed SPRINTER, yes we would be in a much stronger position. But they can now say to Synairgen we can go toddle off, spend years trying to prove this in further trials, burning through cash to keep the lights on and salaries paid, with no guarantees of success at the end. Or, cut your losses with £1.

I so wanted this to succeed. And it may well do. But offer me £1 right now... I'd probably take it. (My average is almost identical to Polygon).

Manifesto, I think Polygon's average in price is now around £1.

Unfortunately, Synairgen don't have much to offer in a negotiation right now. Large pharma could tell us to go or our life, spend another couple of years on trials, burning through cash, with no guarantees at the end. Or sell out now for 50-100p, Polygon and other large early adopter shareholders get out for a small loss or breaking even where they can reinvest into something else rather than being tied up.

It's all guesswork. But I don't think anything will happen before ACTIV-2 P2 data arrives and SPRINTER deep dive is done. Pray they are both good and we might just limit the damage.

Docdaneeka - in your opinion, the odds of a takeover happening? For me, it is still only 10-20% chance. This could be a long, hard road ahead.

Burstead- unfortunately there is definitely not always success in the long term.

However, if you do ultimately think there will be success here, why not stop having a go at all the so called rampers? If you think there is a positive ending, no matter how far into the future it might be, then they are doing prospective investors a favour?

Or maybe try to doing/sharing your own research or engaging in a healthy debate?

At the moment, you are bringing nothing to the party.

Burstead- you never did answer my question..

As a fellow investor in Synairgen, what do you see as the end game here? Success in the long term, complete failure, takeover?

I seriously doubt they’ll be an EUA (5-10% chance, tops). That leaves either more trials, taking potentially years from start to finish. Or a TO. But to be taken over for any kind of reasonable price (even 50p +) we’ll need great ACTIV 2 P2 data and/or a real gem(s) from the SPRINTER deep dive. Without these, we’ve not got a lot else… an idea, some all but useless patents, biobank and plenty of big salaries.

Lots of people probably crystallising their considerable losses to offset against their gains. Hopefully buying back in tomorrow inside their ISAs!

Burstead, you say you are invested here. So what is your end game here...what do you see or expect to happen?

Hallelujah! RM finally back in front of the cameras.

You can see a lot of stress and disappointment behind those eyes ( I think a lot of us are feeling the same), but good to see him and they they are working hard on this. Sit tight for May and maybe ACTIV P2 data before or by then, too.

The RNS from early March says that findings from the deep dive analysis “will be announced without delay”. Today’s RNS reads like there will be nothing until this event in May. As Tommy says, that seems a bit odd. To prepare for such a presentation, they’d need some time… even if it’s days. So “announced without delay” should mean an RNS in advance of this presentation.

Manifesto, I don’t think Synairgen knew exactly when they would get ACTIV P2 data. They would have probably been told by the US some time soon, and first half of 2022 covers them. So IMO I wouldn’t rule that out.

I wonder if they have anything on long Covid yet…

You could be right with SPRINTER deep dive. After all, it’s been 6 weeks since that awful day… 6 weeks of teams of people poring over the data. I think that’s long enough.

I just fear we will end up disappointed again with no real news. However, as long as it’s not bad news I won’t be able to complain, seeing as I have been saying RM needs to face the cameras, even if it’s just for a flirt with Katie.

Let’s keep our feet on the ground. Manifesto, it could have been one of the other stocks mentioned who asked for it to be deleted.
Of course, I hope it is positive… something like they now have the ACTIV P2 data and it’s really encouraging.

I hope you’re right, Docdaneeka.

It’s been so long since we had some good news, that I almost can’t imagine it.

Prion, I don’t think they’d have mentioned RM by name if it was a mix up with another company.

It’s probably just that one of those mentioned didn’t want to be… maybe there is an announcement to be made. But not necessarily from Synairgen.

Whatever it is, nothing is ever easy with Synairgen!

Mimillasa - That is very old and was when we passed phase 2 of ACTIV.

Being invested in Synairgen is like torture. Dangling a carrot of a measly interview, allowing us to get a bit excited for just a slither of potential news, even for that to be taken away from us!!

Wigster - let's wait and see! I have visions of a Spitting Image type dummy doing the interview! :D

Joking aside, it's good he's finally facing up to the cameras and I truly hope he has something at least vaguely positive. We're due some good news. Or even average news!